European shares slip on tech, banks drag; clocks weekly gains

Carlsberg slides after Britvic rejects takeover bid

*

Switzerland's ABB down on DB downgrade

*

STOXX 600 down 0.7%, but logs weekly gains

June 21 (Reuters) - European shares closed lower on Friday, pressured by falls in technology and bank stocks, while Danish brewer Carlsberg Group was the day's worst performer after British soft drinks maker Britvic rejected its revised takeover proposal.

The Europe-wide STOXX 600 ended 0.7% lower, with the technology sub-index losing around 1.3% and euro zone banks sliding 1.7%.

Carlsberg Group dropped 9.3% after Britvic rejected its $3.93 billion takeover bid, saying that the proposal "significantly undervalued" the group and its prospects. Britvic jumped 7.7%.

Still, the European benchmark recorded a weekly gain of 0.8% as the market focused on Swiss and British central bank decisions in the week, recovering from last week's drop after French President Emmanuel Macron called a snap parliamentary election.

"We are gingerly recovering, but the volatility will remain with regard to the French elections going forward until the first date of the election," said Axel Rudolph, senior market analyst at IG Group.

The French benchmark CAC 40 index recorded a gain of 1.7% for the week.

On the data front, France's services sector contracted more than expected in June, while a broader euro zone reading showed that business growth in the bloc slowed sharply this month as demand fell for the first time since February.

"It is possible that at least French consumers will be happier with the election result and the fiscal promises than businesses, and continue to spend," Citigroup strategists said in a note.

"However, if growth slows materially, chances of more and faster ECB rate cuts would rise."

An upturn in business activity in

Germany

, the bloc's largest economy, also slowed in June, data showed.

Government bond yields across the continent slipped after the data release.

Britain's blue-chip FTSE 100 slipped 0.4%, as a hot domestic retail sales reading stoked concerns that interest rates would stay elevated for longer.

Global investors remained risk-averse as U.S. equities traded in the red, as a rally in chipmaking giant Nvidia appeared to fizzle out.

Among other stocks, Denmark's Zealand Pharma jumped nearly 19% after an early-stage study showed a high dose of its drug helped reduce weight by an average 8.6% after 16 weekly doses.

British discount chain B&M fell 1.7% after Morgan Stanley lowered its rating to "underweight" from "equal-weight".

Shares in ABB shed 2.8% after Deutsche Bank downgraded the Swiss engineering group to "sell". (Reporting by Shashwat Chauhan and Shristi Achar A in Bengaluru and Jesus Calero in Gdansk; Editing by Sherry Jacob-Phillips and by Kevin Liffey)